Voloridge Investment Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-41,414
| Closed | -$307K | – | 1243 |
|
|
2024
Q1 | $307K | Sell |
41,414
-513,983
| -93% | -$3.81M | ﹤0.01% | 1089 |
|
|
2023
Q4 | $5.63M | Buy |
+555,397
| New | +$5.63M | 0.02% | 589 |
|
|
2023
Q3 | – | Sell |
-407,001
| Closed | -$3.35M | – | 1442 |
|
|
2023
Q2 | $3.35M | Buy |
407,001
+192,692
| +90% | +$1.59M | 0.02% | 817 |
|
|
2023
Q1 | $1.55M | Buy |
+214,309
| New | +$1.55M | 0.01% | 1039 |
|
|
2022
Q3 | – | Sell |
-452,140
| Closed | -$5.35M | – | 1443 |
|
|
2022
Q2 | $5.35M | Sell |
452,140
-289,376
| -39% | -$3.42M | 0.03% | 647 |
|
|
2022
Q1 | $14.1M | Buy |
741,516
+72,756
| +11% | +$1.38M | 0.08% | 325 |
|
|
2021
Q4 | $17.8M | Buy |
668,760
+254,096
| +61% | +$6.75M | 0.1% | 296 |
|
|
2021
Q3 | $17M | Buy |
414,664
+200,853
| +94% | +$8.25M | 0.11% | 251 |
|
|
2021
Q2 | $12.1M | Sell |
213,811
-60,470
| -22% | -$3.42M | 0.08% | 335 |
|
|
2021
Q1 | $11.5M | Sell |
274,281
-131,545
| -32% | -$5.52M | 0.08% | 316 |
|
|
2020
Q4 | $28.5M | Buy |
+405,826
| New | +$28.5M | 0.24% | 97 |
|
|
2020
Q1 | – | Sell |
-34,624
| Closed | -$1.03M | – | 1157 |
|
|
2019
Q4 | $1.03M | Buy |
+34,624
| New | +$1.03M | 0.02% | 650 |
|